VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1482050
Sex: F
Age:
State: CA

Vax Date: 03/24/2021
Onset Date: 03/25/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Fever; Headache; Chills; Muscle ache; This is spontaneous report from contactable consumer, the patient. A 17-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727), via an unspecified route of administration in right arm on 24Mar2021, (at the age of 17-years -old), as a single dose for COVID-19 immunisation. The patients medical history was reported as reported as not applicable and she had no known allergies. The concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198), via an unspecified route of administration in right arm, on 02Mar2021 at 17:30, (at the age of 17-years-old), as a single dose for COVID-19 immunisation. the patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 25Mar2021 at 17:15, the patient experienced fever, headache, chills and muscle ache. The events had not resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No treatment was received for the events. The clinical outcome of fever, headache, chills and muscle ache was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482051
Sex: F
Age:
State: AZ

Vax Date: 03/25/2021
Onset Date: 03/25/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: This is a spontaneous report received from a non contactable consumer, the patient. A 46-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via unspecified route of administration on left arm on 25Mar2021 at 14:30 (at the age of 46- year-old) as a single dose, for COVID-19 immunisation. Past medical history included Novocain allergy. Concomitant medication was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 25Mar2021 at 15:15 the patient experienced difficulty breathing, red and slightly swollen face, irregular pulse, dizziness. The event resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care visit. No therapeutic measure was taken in response to the event. The clinical outcome of the event difficulty breathing, red and slightly swollen face, irregular pulse, dizziness was resolving at the time of this report. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1482052
Sex: M
Age:
State:

Vax Date: 03/13/2021
Onset Date: 03/13/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: sore left arm; also had diarrhea from Saturday to Tuesday and my stool was bright yellow.; This is a spontaneous report from a contactable consumer, the patient. A 27-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208) via unspecified route of administration in the left arm on 13Mar2021 (at the age of 27-year-old) at 15:00 as a single dose for COVID-19 immunization. Medical history included asthma and COVID-19. The patient had no known allergies. Concomitant medication was not reported. The patient did not receive any other vaccine within four weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 13Mar2021 at 21:00, the patient experienced a sore left arm, diarrhoea from Saturday to Tuesday and his stool was bright yellow, which was not too serious. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the adverse events. The clinical outcome of sore left arm was recovered on 15Mar2021, while that of diarrhoea was recovered on 16Mar2021 at the time of this report. No follow-up attempts are needed. No further information is expected. Amendment: This follow-up report is being submitted to amend previously reported information: Prior to vaccination, was the patient diagnosed with COVID-19? Yes, added as Relevant Med History and vaccination Facility Country added.

Other Meds:

Current Illness:

ID: 1482053
Sex: M
Age:
State: CA

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Spike in BP; Spike in heart rate; Lighted; This is a spontaneous report received from a contactable consumer (patient). A 63-years-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EP8727), via an unspecified route on 19Mar2021 at 10:15 (at age of 63-years old) as dose 2, single in the left arm for covid-19 immunisation. The patient medical history included thyroid, high cholesterol. The patient had no known allergies. The patient concomitant medications included levothyroxine with dose 125mcg and Atorvastatin with dose 20mg from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6201), via an unspecified route on 26Feb2021 (at age of 63-years old) as dose 1, single for covid-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 19Mar2021 at 12:00, the patient experienced spike in BP, spike in heart rate and lighted. The patient received treatment IV fluids for events. The event resulted in emergency room visit The reporter assessed the case as non-serious. The outcome of the events was recovering.

Other Meds: LEVOTHYROXINE; ATORVASTATIN

Current Illness:

ID: 1482054
Sex: F
Age:
State: ID

Vax Date: 03/25/2021
Onset Date: 03/26/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Body chills; Body aches; This is a spontaneous report from a non-contactable consumer, the patient. A 53-year-old non pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the right arm on 25Mar2021 at 14:45 (at the age of 53-years-old), as single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis, diabetes, compromised immune system and COVID-19, which was diagnosed prior to the vaccination. Concomitant medication was not reported. The patient previously took morphine (MANUFACTURER UNKNOWN) for unspecified indication and experienced allergy. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 26Mar2021 at 04:15, the patient experienced body chills and body aches. The patient did not receive any treatment for the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events body chills and body aches was resolving at the time of report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1482055
Sex: F
Age:
State: TX

Vax Date: 03/15/2021
Onset Date: 03/15/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: slightly sore arm; tiredness; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the left arm on 15Mar2021 at 12:30 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included ulcerative colitis. Concomitant medication included paracetamol(TYLENOL), CBD salve (MANUFACTURER UNKNOWN), biotin vitamin (MANUFACTURER UNKNOWN) and moringa tea (MANUFACTURER UNKNOWN)) from unknown date for unspecified indication. The Patient did not have any allergies to medications, food, or other products, but can't take ibuprofen. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the Patient had not tested for COVID-19. On, 15Mar2021 the patient experienced tiredness and slightly sore arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the tiredness and slightly sore arm was resolved on unknown date in Mar2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: TYLENOL; biotin vitamin

Current Illness:

ID: 1482057
Sex: F
Age:
State: MD

Vax Date: 03/25/2021
Onset Date: 03/25/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received a first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730), via an unspecified route of administration in left arm on 25Mar2021 at 15:00 (at the age of 63-years-old) as a single dose for COVID-19 immunization. Medical history included low thyroxine, mildly elevated cholesterol, sprain and tendinitis. The patient had an allergic reaction to bee sting, had an allergic response to tetanus shot 40 years ago and had minor seasonal dust allergy and had outgrew sporadic childhood chocolate and strawberry allergies. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN), SYNTHROID and vitamin D (MANUFACTURER UNKNOWN) for unknown indications from unknown date. The patient had received other vaccine PROLIA, within 4 weeks prior to the COVID-19 vaccine in the arm on 04Mar2021 for an unknown indication. The patient had not been diagnosed with COVID-19 prior to the vaccination. The patient had not been tested for COVID-19 since the vaccination. On 25Mar2021, at 16:30, the patient had experienced numbing of lips, approximately 80 min after shot. The patient had received benadryl, followed by zantac as treatment for the events which prevented escalation. The patient had called the doctor later. The clinical outcome of numb lips was recovered at the time of report. No follow-up attempts are needed; No further information is expected.

Other Meds: SYNTHROID; ATORVASTATIN; vitamin D

Current Illness:

ID: 1482059
Sex: M
Age: 33
State: CO

Vax Date: 05/21/2021
Onset Date: 07/01/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies: None

Symptom List: Pharyngeal swelling

Symptoms: Numbness tingling and moderate paralysis and loss of motor function in left pinky, left thumb, left index, left forearm, left shoulder, left neck, left jawline, bottom lip of mouth, right shoulder

Other Meds: None

Current Illness: None

ID: 1482060
Sex: F
Age: 40
State: MN

Vax Date: 07/15/2021
Onset Date: 07/17/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies: Rocephin, Latex,

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Some soreness on the left arm day of and the next day after the shot. 7/16 some muscle aches and really fatigued around 3:00p.m. On 7/17 fatigued, hand tremors and joint pain.

Other Meds: Magnesium, Vitamin D, Vitamin B complex

Current Illness: Long term COVID

ID: 1482061
Sex: M
Age: 19
State: AZ

Vax Date: 07/17/2021
Onset Date: 07/17/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies: no known allergy

Symptom List: Diarrhoea, Nasal congestion

Symptoms: patient came up to rx counter stated he wasn't feeling well his eyes rolled into the back of his head and he passed out we called 911 he was assessed and they recommended to not transport him since vitals were okay

Other Meds: none

Current Illness: no

ID: 1482062
Sex: F
Age: 32
State: TX

Vax Date: 07/09/2021
Onset Date: 07/15/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies: No

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Six days after the shot (Thursday morning 07/15) my left armpit was sore. The following evening (Friday 07/16) I noticed red bumps/rash on my upper arm where the injection site was; it resembled and insect bite. Throughout the evening, the red bumps turned into a painful, itchy rash with hot-to-touch hard lump, that was about the size of a quarter. The next day (Saturday 07/17) the rash had progressed and worsened; it is very hot to touch, large lump under skin, swollen, very red. The area had grown to consume most of my upper arm. Later Saturday afternoon, I began to feel very hot, took my temperature and had a fever 100.00 and decided to go to an urgent care. I was diagnosed as an allergic reaction and cellulitis. I was giving three shots: 1. Decadron and the other two shots were Clindamycin. I will begin Clindamycin capsule tomorrow.

Other Meds: Adderall

Current Illness: Stomach virus

ID: 1482063
Sex: F
Age: 22
State: TX

Vax Date: 03/12/2021
Onset Date: 03/21/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies: I am allergic to Penicillin, Cefzil, Sulfa drugs, and real Christmas trees.

Symptom List: Rash, Urticaria

Symptoms: I have been having trouble breathing since I had the vaccine done. I get really bad chest pains just from laying down and it is a daily struggle to do everyday things like walking because I get short of breath really easily after I had the vaccine done. It has been 3 and a half months now and I am still struggling trying to recover. My treatment right now is that my pulmonologist put me on Symbicort to see if it could give me a little bit of relief and I am still being seen by the cardiologist as well, and I am also using my rescue inhaler Albuterol HFA more often than before. I am taking Singulair and I was also put on a heart monitor for 2 days to check my heart rhythm to see if that has anything to do with the chest pains I have been feeling

Other Meds: I had just taken Tylenol before I had my COVID vaccine done and albuterol inhaler as needed, but have not used it since 2015.

Current Illness: N/A

ID: 1482064
Sex: F
Age: 62
State: FL

Vax Date: 06/29/2021
Onset Date: 07/12/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies: Ceclor

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: On 7/12/21 started getting sharp pains left side it felt like it was in my heart then on July 13, 2021 I want to hospital. The ER they did bloodwork many test chest x-ray the final diagnosis was pleurisy. I have never had any lung issues in my life except asthma when I was a young child which I out grew it as a teenager. I am following up with a pulmonologist on Monday, July 19, 2021 as advised.

Other Meds: Eperlone 25 mg

Current Illness: None

ID: 1482065
Sex: F
Age:
State:

Vax Date: 03/25/2021
Onset Date: 03/25/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Left arm is sore.; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 25Mar2021 at 13:45 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN), via an unspecified route of administration on 24Feb2021 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. On 27Feb2021, the patient underwent nasal swab test for SARS-CoV-2 and result was found to be negative. On 25Mar2021 at 16:00, the patient's left arm was sore. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient had not received treatment for the adverse event. The clinical outcome of the event left arm sore was recovering at the time of report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1482066
Sex: F
Age: 60
State: AL

Vax Date: 06/24/2021
Onset Date: 06/24/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies: Periactin I?ve vancomycin

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Moderate to moderately severe constant SOB WO WHEEZING

Other Meds: Vybanse klonopin

Current Illness: NO

ID: 1482067
Sex: F
Age: 71
State: AZ

Vax Date: 04/27/2021
Onset Date: 04/27/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies: PCN, sulfonamides

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Became dizzy immediately,. Severe weakness and fatigue with nausea persisted for about three weeks. Weakness and fatigue are still resolving. It's the same reaction as to the fir vaccination, only more severe and longer lasting.

Other Meds: Estradiol, Linzess, Amitriptylline Hcl

Current Illness: Had just recovered from the same severe reaction to the first Moderna vaccination.

ID: 1482068
Sex: M
Age: 54
State: CA

Vax Date: 05/18/2021
Onset Date: 06/01/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies: none

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Tennitus, hissing sound in both ears; louder on the right side

Other Meds: none

Current Illness: no illnesses

ID: 1482069
Sex: M
Age: 35
State: TX

Vax Date: 04/03/2021
Onset Date: 04/18/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies: None

Symptom List: Ear pain, Hypoaesthesia

Symptoms: On April 19th, 16 days after vaccine administered, massive headaches began that left me bed ridden for roughly 2 weeks to a month afterwards. Severe headaches lasted all day with no breaks. Only relief I would have would be from laying down with head in a certain position. A month after initial symptoms, the pain started to subside, but very slowly, taking several more weeks to calm down and to feel reduction in pain. Pressure would also set in around brain when pain was becoming less. Several tests had been done after symptoms began which included: Bloodwork Lipid CT Scan without contrast CT Scan with contrast MRI without contrast On June 15th, I was notified by my Neurologist that the MRI, which had been performed on June 10th, had showed a mild stroke had recently occurred. I am now on blood pressure medication, as well as aspirin 81, reduce the likelihood of another stroke.

Other Meds: Aleve Quercetin 500mg Supplement, Zinc 50mg, Vitamin C, Vitamin D3, Bromelain Fish Oil

Current Illness: None

ID: 1482070
Sex: F
Age: 71
State: AZ

Vax Date: 03/23/2021
Onset Date: 04/27/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies: PCN, sulfonamides

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Felt dizzy immediately. Severe weakness and fatigue began that night, worse the second day, with nausea. Persisted for three weeks and was just resolving when I had the second vaccination. When there is a booster, I'll have that.

Other Meds: Estradiol, linzess, amitriptylline Hcl

Current Illness: NA

ID: 1482071
Sex: F
Age: 71
State: HI

Vax Date: 12/28/2020
Onset Date: 04/15/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies: None

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Shingles

Other Meds: Praluent Restasis Progesterone

Current Illness: Nonr

ID: 1482072
Sex: M
Age:
State:

Vax Date: 03/22/2021
Onset Date: 03/22/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: developed severe body aches and pain; severe headache; This is a spontaneous report from a non-contactable consumer, the patient. A 56-years-old male patient received first dose of BNT162b2(PFIZER-BIOTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Batch/Lot number: UNKNOWN) via an unspecified route of administration on 22Mar2021 (at the age of 56-year-old) for COVID-19 immunization. The patient medical history was not reported. The patient had no allergies to medications, food, or other products. The patient concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in Mar2021, within 12 hours of receiving the first vaccine, the patient developed severe body aches and pain and also a severe headache. These symptoms were still present 24 hours later. The patient did not receive any treatment for the events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events was severe headache and severe body aches, and pain was not recovered on an unspecified date at the time of this report. Amendment: This follow-up report is being submitted to amend previously reported information: This is a spontaneous report from a contactable consumer, the patient" updated as "Non-contactable. For both events "developed severe body aches and pain" and "severe headache": Onset updated from "Mar2021" to "22Mar2021" per vaccination date 22Mar2021 and PRD 23Mar2021 and verbatim "These symptoms were still present 24 hours later". Adverse event Within 12 hours of receiving the first vaccine I developed severe body aches and pain. Also, a severe headache. These symptoms were still present 24 hours later. Event occurred in country. And events were not recovered on an unspecified date. The patient didn't receive any treatment. No follow-up attempts are possible; information about lot/batch number cannot be obtained

Other Meds:

Current Illness:

ID: 1482073
Sex: F
Age:
State: MA

Vax Date: 03/20/2021
Onset Date: 03/20/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Ringing in both ears,; fullness feeling in both ears; This is a spontaneous report from a contactable other healthcare professional, the patient. A 52-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER2613) via an unspecified route of administration in the left arm on 20Mar2021 at 12:45 (at the age of 52-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had a history of allergy to aspirin and sulfur. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) and levothyroxine sodium (SYNTHROID) for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 20 Mar2021 at 15:45, the patient had experienced ringing and fullness feeling in both ears. Adverse events resulted in doctor or other healthcare professional office/clinic visit. It was unknown if the patient had received any therapeutic measures for the reported events. The clinical outcome of the events ringing and fullness feeling in both ears was not resolved at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: LISINOPRIL; SYNTHROID

Current Illness:

ID: 1482074
Sex: M
Age:
State: CT

Vax Date:
Onset Date:
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Arm pain after vaccination #1; This is a spontaneous report from a contactable consumer. A 47-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration on an unknown date (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. It was unknown if the patient was diagnosed with COVID-19, prior to the vaccination. It was unknown if the patient had been tested for COVID-19, since the vaccination. It was unknown if the patient had received any other vaccines within four weeks prior to the COVID vaccine. On an unknown date, the patient experienced arm pain after vaccination #1. It was unknown if the patient had received any treatment for the event arm pain after vaccination #1. The clinical outcome of the event arm pain after vaccination #1 was unknown at the time of the report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1482075
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: redness on neck and chest; headache; This is a spontaneous report from a non-contactable consumer, the patient. A 19-year-old female patient received BNT162b2 (COVID-19 MRNA VACCINE BIONTECH; lot number: ER8727) via an unspecified route of administration on an unknown date as a single dose for COVID 19 immunization (at the age 19-years-old). Medical history included dysautonomia and autoimmune autonomic ganglionopathy and past drug include amoxycillin. The patient had a history of allergy to penicillin and tree nuts. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. On an unspecified date in 2021, the patient experienced redness on neck and chest and headache. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events redness on neck and chest and headache was unknown at the time of report. No follow-up attempts are possible. No further information is expected. Follow-up (01Jul2021) Amendment: This follow-up report is being submitted to amend previously reported information: Verbatim in other relevant history tab row 1 and row 2 , updated to known allergies: penicillin and known allergies : tree nuts. Past Drug Event Amoxycillin was recoded to AMOXYCILLIN, not Amoxycillin. Relevant history autoimmune autonomic gangliopathy added. Final sentence should be updated to: No follow-up attempts are possible. No further information is expected. For all events, onset date added as 2021

Other Meds:

Current Illness:

ID: 1482076
Sex: M
Age:
State: SC

Vax Date: 03/23/2021
Onset Date: 03/24/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Dizzy; diarrhea; nausea; fever; tired; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN620), via an unspecified route of administration in the left arm on 23Mar2021 at 09:45 (at the age of 62-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to medications, food, or other products. Concomitant medication included cetirizine hydrochloride (ZYRTEC) for an unspecified indication from unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021, the patient experienced dizzy, diarrhea, nausea, fever and tired. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the dizzy, diarrhea, nausea, fever and tired was recovering at the time of report. No follow-up attempts are needed. No further information expected.

Other Meds: Zyrtec

Current Illness:

ID: 1482077
Sex: M
Age:
State: PA

Vax Date: 03/23/2021
Onset Date: 03/23/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: trouble sleeping; Fatigue,; general muscle soreness all over; injection site soreness; skin redness at injection site; headaches; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203), via an unspecified route of administration in the left arm on 23Mar2021 at 11:00 (at the age 48-years-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol, GERD and sleep apnea. The patient was allergic to casein and dust mites. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included fexofenadine hydrochloride (ALLEGRA), paracetamol (TYLENOL), pravastatin (MANUFACTURER UNKNOWN), famotidine (MANUFACTURER UNKNOWN) and ESCILOP, all for unknown indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203), via an unspecified route of administration in the left arm on 01Mar2021 at 10:30 (at the age 48-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 23Mar2021 at 23:00, the patient experienced fatigue, general muscle soreness all over, injection site soreness, skin redness at injection site, headaches and had trouble sleeping. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient received treatment with paracetamol (TYLENOL) for the events fatigue, general muscle soreness all over, injection site soreness, skin redness at injection site, headaches and trouble sleeping. The clinical outcomes of the events fatigue, general muscle soreness all over, injection site soreness, skin redness at injection site, headaches and trouble sleeping were recovering at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: ALLEGRA; TYLENOL; PRAVASTATIN; FAMOTIDINE

Current Illness:

ID: 1482078
Sex: F
Age:
State: MA

Vax Date: 03/25/2021
Onset Date: 03/25/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: severe headache at back of head behind earon side of injection.; feeling a strong tingling in my neck, jaw and inner ear on side of injection site; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: ER8733) via an unspecified route of administration in the left arm on 25Mar2021 (at the age of 63-years-old) at 11:00 as a single dose for COVID-19 immunisation. Medical history included high cholesterol. No known allergies were reported for the patient. Concomitant medications included atorvastatin 10 mg (MANUFACTURER UNKNOWN) for unknown indication received within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had not been tested for COVID-19, since the vaccination. On 25Mar2021 at 12:30, about 1.5 hours after the vaccination, the patient started feeling a strong tingling in her neck, jaw and inner ear on side of injection site which stayed all day but lessened after about 6 hours. In the next day morning after 22 hours, on 26Mar2021, the patient had severe headache at back of head behind ear on side of injection. The patient did not receive any treatment for the reported events. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events feeling a strong tingling in my neck, jaw and inner ear on side of injection site and severe headache at back of head behind ear on side of injection was resolving at the time of this report. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ATORVASTATIN

Current Illness:

ID: 1482079
Sex: F
Age:
State: CA

Vax Date: 03/25/2021
Onset Date: 03/26/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Extremely high fever keeps gettinghigher.; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via unspecified route of administration in the left arm on 25Mar2021 at 10:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via unspecified route of administration in the left arm on 04Mar2021 at 12:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have allergies to medications, food, or other products. On 26Mar2021 at 02:00, the patient experienced extremely high fever which keeps getting higher and currently over 103 (unit unspecified). The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported event. The clinical outcome of the event extremely high fever was not resolved at the time of this report. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1482080
Sex: M
Age:
State: SC

Vax Date: 03/25/2021
Onset Date: 03/25/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Sore injection site; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old-male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: ER8739) via unspecified route of administration in the left arm on 25Mar2021 at 10:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included obesity, COVID-19 and diabetes. The patient was allergic to penicillin. Concomitant medication included metformin (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN) and lisinopril (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not tested for COVID-19. On 25Mar2021 at 13:00, the patient experienced sore vaccination site and headache. The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient did not receive treatment for the reported events. The clinical outcome of vaccination site pain and headache was resolving at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: METFORMIN; BUPROPION; LISINOPRIL

Current Illness:

ID: 1482081
Sex: F
Age:
State: FL

Vax Date: 03/08/2021
Onset Date: 03/01/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: blisters on mygumline; large sores on my gums and inbetween some teeth; painful; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: Unknown,) via an unspecified route of administration in the left arm on 08Mar2021 at 08:00 (at the age of 51-years-old), as a single dose for COVID-19 immunisation. Medical history included carotid artery dissection in 2015. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), aspirin (MANUFACTURER UNKNOWN) and atorvastatin (MANUFACTURER UNKNOWN); all for unknown indication and from an unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 09 Mar2021, the patient noticed blisters on the gum line. The blisters continued and got more worse and severe as the weeks passed. On an unknown date in Mar2021, the patient had large sores on the gums and in between some teeth. The gum sores were not painful in the beginning but were very painful and irritating at the time of this report. The patients tongue, under the tongue, inner cheeks, and the roof of the mouth were clear of blisters. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events blisters, sores gum and gum pain were not recovered at the time of this report. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: Aspirin; LEVOTHYROXINE; LISINOPRIL; ATORVASTATIN

Current Illness:

ID: 1482082
Sex: F
Age:
State:

Vax Date: 03/25/2021
Onset Date: 03/25/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Left side of my body, especially my face and head, felt numb after getting the vaccine.; This is a spontaneous report from a non-contactable consumer, the patient. A non-pregnant female patient of unknown age received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8730); via an unspecified route of administration in the left arm on 25Mar2021 (at the age 57-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had a history of known allergies to penicillin. The concomitant medications included colchicine (MITIGARE), calcium (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN), vitamin d (MANUFACTURER UNKNOWN), ascorbic acid; retinol; tocopherol (OCUVITE), vitamin b (MANUFACTURER UNKNOWN) for an unknown indication. The patient did not receive any other vaccine within 4 weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 25Mar2021, the patient experienced numbness on the left-side of body, especially on face and head. The patient did not receive any treatment for reported events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of event numbness on the left-side of the body, especially on face and head was resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: MITIGARE; CALCIUM; MAGNESIUM; Vitamin d; Ocuvite; VITAMIN B

Current Illness:

ID: 1482083
Sex: M
Age:
State: VA

Vax Date: 03/24/2021
Onset Date: 03/24/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Restless legs; Headache; Fatigue; Injection site pain; Muscle pain; Chills; Fever 100.6; Joint pain; Malaise; This is a spontaneous report from a contactable healthcare professional, the patient. A 59-years-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot no: ER8727) via an unspecified route of administration in the left arm on 24Mar2021 at 15:30 (at the age of 59-years-old), as a single dose for COVID-19 immunisation. No medical history was reported. The patient did not take any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not report any known allergies to medications, food, or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198) via an unspecified route of administration in the left arm on 05Mar2021 at 13:30 (at the age of 59-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021 at 22:15, the patient experienced headache, fatigue, injection site pain, muscle pain, chills, fever 100.6, joint pain, malaise and restless legs. The patient received treatment for event fever 100.6 with acetaminophen(TYLENOL). It was reported that the events had not resulted in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. The clinical outcomes of events headache, fatigue, injection site pain, muscle pain, chills, fever 100.6, joint pain, malaise and restless legs were resolving at the time of the report. No follow-up attempts possible. No further information expected.

Other Meds:

Current Illness:

ID: 1482084
Sex: F
Age:
State: TN

Vax Date: 03/22/2021
Onset Date: 03/22/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Headache; face/neck pain; Neck pain; sore arm; Tired; This is a spontaneous report from a contactable consumer, the patient. A 54-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727) via an unspecified route of administration in the left arm on 22Mar2021 at 10:15 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. The patient medical history included high cholesterol and hypothyroidism (low thyroid). Concomitant medications included progesterone (MANUFACTURER UNKNOWN), rosuvastatin (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN) and estradiol (MANUFACTURER UNKNOWN) for unknown indications from unknown dates. The patient has known allergy to hydrocodone and it makes her itchy. Prior to vaccination, patient had not diagnosed with COVID-19. Since the vaccination, patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Mar2021 at 18:00 (night at vaccination day), the patient had sore arm and was tired. On 23Mar2021 (second day), the patient was fine but, in the evening, experienced headache with torso and face/neck pain and was fine the third day. Therapeutic measures were taken as a result of the events which included over the counter medication TYLENOL. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events painful arm, tiredness was resolved on 23Mar2021, whereas for events headache, facial pain, neck pain and pain were resolved on 24Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds: PROGESTERONE; ROSUVASTATIN; LEVOTHYROXINE; ESTRADIOL

Current Illness:

ID: 1482085
Sex: F
Age:
State: VA

Vax Date: 03/22/2021
Onset Date: 03/22/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Woke up with a huge left blood shot eye; Everything was so bright; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8730), via an unspecified route of administration in the left arm on 22Mar2021 at 17:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, laser surgery for a detached retina one and half years ago and allergy to latex gloves. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received unspecified concomitant medications within two weeks of vaccination. The patient previously received oxycodone; aspirin (PERCODAN) and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 22Mar2021 at 22:00, the patient was watching television, and all of a sudden, she had to turn off the television and lights because everything was so bright and the patient went to bed. On 23Mar2021 at 06:30, the patient woke up with a huge left blood shot eye. It was reported that the patient had never experienced a blood shot eye before, and this was the eye she had laser surgery for a detached retina one and half years ago. The patient had just gone to retina doctor two weeks prior to the vaccine and her eye was doing great. The adverse events resulted in a visit to the doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events everything was so bright and woke up with a huge left blood shot eye. The clinical outcomes of the events everything was so bright and woke up with a huge left blood shot eye were recovering at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482086
Sex: M
Age:
State: VA

Vax Date: 03/24/2021
Onset Date: 03/24/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Slight fever of 99.8 the evening of the shot; Sinus congestion; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE BIONTECH, Lot number: EN6199) via an unspecified route of administration in the left arm on 24Mar2021 at 14:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient medical history included irregular heartbeat. The patient previously had drug allergy while taking diclofenac sodium (MANUFACTURER UNKNOWN). Concomitant medications included mirtazepine (REMERON), metoprolol (MANUFACTURER UNKNOWN) and krill oil (MANUFACTURER UNKNOWN) all used for an unknown indication and were started on an unknown date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 24Mar2021, the patient had sinus congestion almost immediately and on the same day in the evening at 19:00, the patient had a slight fever of 99.8 (units unspecified). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the adverse events. The clinical outcomes of the events fever and sinus congestion were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: REMERON; METOPROLOL; KRILL OIL

Current Illness:

ID: 1482087
Sex: F
Age:
State: CT

Vax Date: 03/23/2021
Onset Date: 03/25/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: 3 weeks early and heavy period; 3 weeks early and heavy period; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: EL3247), via an unspecified route of administration in left arm on 23Mar2021 at 11:45 (at age of 24 years old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Patient previously received the first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: EL3247), via an unspecified route of administration in left arm on 04Mar2021 at 09:00 (at age of 24 years old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 25Mar2020 at 12:00 after the vaccination, the patient reported she experienced 3 weeks early and heavy period. No therapeutic measures were taken for the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event 3 weeks early and heavy period was recovered on an unknown date in Mar 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482088
Sex: F
Age:
State:

Vax Date: 03/24/2021
Onset Date: 03/25/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Minor left arm pain; low grade fever of 99.2F the next day; Nausea for most of the next day; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955), via unspecified route of administration in the left arm on 24Mar2021 at 08:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. No medical history and concomitant medications were reported. No known allergies were reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248), via unspecified route of administration in the left arm on 04Mar2021 at 07:45 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 25Mar2021 (reported as next day of vaccination), the patient had experienced minor left arm pain, low grade fever of 99.2-degree F and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcomes of the events mild left arm pain, low grade fever and nausea was recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1482090
Sex: F
Age:
State:

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: This is a spontaneous report received from a non-contactable consumer (patient). A 32-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot no: EM9809) via an unspecified route on her left arm on 19Mar2021, at 14:00 as a dose2, single for COVID-19 immunisation (at the age of 32-Years-old). The patient did not have any medical history. Patient did not have any allergies to medications, food, or other products. The patient was not diagnosed with COVID-19 prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. It was reported that the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive other medications within 2 weeks of vaccination. The patient historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EM9808) via an unspecified route of administration on her left arm on 26Feb2021, as a dose 1, single for COVID-19 immunisation (vaccinated at 32years old). On 19Mar2021, after approximately 6.5 hours following second vaccination the patient had sudden and acute back pain. The patient stated that the pain was located primarily on left side in the middle back, although there were some sharp pains on the right side (middle) and left lower back, sharp pains would come and go intermittently, multiple times in the first 24 hours and then about twice a day for the following three days, pain was lingered on day 4 though that was mostly a sore ache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for events. The clinical outcome of acute back pain was recovering at the time of reporting. No follow-up attempts are needed. No further information is expected. DSU Amendment (02July2021): This follow-up report is being submitted to amend previously reported information included 1. Patient country added in patient tab 2. Relevant Med History "None" deleted since Historical Vaccine captured 3. "a contactable patient" updated as "a non-contactable patient" in narrative.

Other Meds:

Current Illness:

ID: 1482091
Sex: F
Age:
State: TN

Vax Date: 03/22/2021
Onset Date: 03/22/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Fatigue; Headache; Nausea; Joint pain; Severe chills; Short of breath; Increased heart rate; Fever; Redness at injection site and below on arm; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ep7534), via unspecified route of administration in the left arm on 22Mar2021 at 11:15 (at the age of 67-years-old), as a single dose for COVID-19 immunisation. Medical history included arthritis, stenosis, seasonal allergies, hiatal hernia and allergy (beta agonists). Concomitant medications included pregabalin (LYRICA), omeprazole (MANUFACTURER UNKNOWN), celecoxib (CELEBREX), loratadine (CLARITIN) and multivitamin (MANUFACTURER UNKNOWN); all from unknown dates for unspecified indications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198), via unspecified route of administration in the left arm on 01Mar2021 at 11:15 (at the age of 67-years-old), as a single dose for COVID-19 immunisation and midazolam hydrochloride (VERSED), fentanyl (MANUFACTURER UNKNOWN), codeine (MANUFACTURER UNKNOWN) and azithromycin (ZITHROMAX); all on unknown dates for unspecified indications and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 22Mar2021 at 23:00, the patient experienced fatigue, headache, nausea, joint pain, severe chills, short of breath, increased heart rate, fever, redness at injection site and below on arm that lasted past day 4. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the events. The clinical outcome of the events fatigue, headache, nausea, joint pain, severe chills, short of breath, increased heart rate, fever, vaccination site erythema was recovering at the time of this report. No follow-up attempts are needed. No further information is expected

Other Meds: LYRICA; CELEBREX; OMEPRAZOLE; Claritin

Current Illness:

ID: 1482092
Sex: F
Age:
State: TX

Vax Date: 03/24/2021
Onset Date: 03/24/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: vaccination site swelling; muscle pain; Nauseous; near syncope; joint pain; Dizziness; Felt like I had the flu but with worse pain and without any upper respiratory symptoms; random pain throughout body.; Pain in the gut; vaccination site arm pain; This is a spontaneous report from a contactable nurse, the patient. A 38-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown), via unspecified route of administration in the left arm on 24Mar2021 at 11:15 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included postural orthostatic tachycardia syndrome, hyperlipidemia, herpes 1 and 2. The patient was allergic to morphine, hydrocodone, jalapenos and kiwi skin. Concomitant medications included beta blocker (unspecified), statin (unspecified), valacyclovir (MANUFACTURER UNKNOWN) from an unknown date taken for herpes simplex type 1 and 2. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 03Mar2021 at 12:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. On 24Mar2021 at 12:30, the patient experienced pain at the injection site (vaccination site pain) arm pain started about an hour after injection. On 25Mar2021, the patient experienced swelling at injection site so bad she could not move her arm (vaccination site swelling); and on 25Mar2021, the patient experienced muscle pain and joint pain were bad enough to keep from doing regular activities, random pain throughout body such as in her gut. Nauseous when the patient attempted physical activity. Felt like the patient had the flu but with worse pain and without any upper respiratory symptoms. Pain kept the patient up at night. The patient also experienced dizziness and near syncope. Arm pain started about an hour after injection, other symptoms started second day and lasted until she woke up on 3rd day. The patient did not receive any treatment for the adverse events. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of vaccination site pain, vaccination site swelling, muscle pain, joint pain, pain, nauseous, flu, dizziness and near syncope was resolved on 26Mar2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: Valacyclovir

Current Illness:

ID: 1482093
Sex: M
Age:
State: PA

Vax Date: 03/13/2021
Onset Date: 03/21/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: A week after 2nd dose, I broke out in red circular somewhat itchy marks and oval welts ranging from small to about an 1" in diameter or length on arms,legs, back, chest.; This is a spontaneous report received from a contactable consumer, the patient. An 82-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9266), via an unspecified route of administration in the right arm on 13Mar2021 at 09:30 (at the age of 82-years-old), as a single dose for COVID-19 immunisation. Medical history included occasional sciatica and some hearing loss. The patient did not have any known allergies to food, medications, or other products. The patient did not receive any other vaccine 4 weeks prior to COVID-19 vaccine. The patient did not receive any other medications within 2 weeks of COVID-19 vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208), via an unspecified route of administration in the right arm on an unspecified date in Feb2021 at 09:30 (at the age of 82-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 21Mar2021 at 17:00, the patient broke out in red circular somewhat itchy marks and oval welts ranging from small to about an 1" in diameter of length on arms, legs, back and chest. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures included treatment with BENADRYL and calamine lotion (MANUFACTURER UNKNOWN). The clinical outcome of welts was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482094
Sex: F
Age:
State: SC

Vax Date: 03/25/2021
Onset Date: 03/25/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: ER8730) via an unspecified route of administration in left arm on 25Mar2021 at 15:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have allergies to medications, food, or other products. On 25Mar2021 at 15.45, the patient experienced red and swollen at injection site with localized pain, a hard lump at injection site, and low-grade fever. The events did not result in doctor or other healthcare professional office/clinic visit. It was unknown if patient received treatment for the events. The clinical outcome of the event vaccination site lump, vaccination site pain, vaccination site swelling, vaccination site erythema and low-grade fever was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482095
Sex: F
Age:
State: MN

Vax Date: 03/26/2021
Onset Date: 03/26/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: This is a spontaneous report received from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204), via an unspecified route of administration in left arm on 26Mar2021 at 09:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The medical history was reported as no. The patient had no known allergies. The concomitant medications included celecoxib (CELEXA), cetirizine hydrochloride (ZYRTEC), montelukast sodium (SINGULAIR), fluticasone propionate (FLONASE), acetylsalicylic acid; paracetamol; caffeine; salicylamide (EXCEDRIN) all for unknown indications. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not tested for COVID-19. The vaccine was administered at the doctors office or urgent care. On 26Mar2021 at 10:15, the patient experienced extremely dry mouth within 10 minutes of vaccine and severe chills. The events had not resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the adverse events. The clinical outcome of the events extremely dry mouth and severe chills was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: Celexa; Zyrtec; SINGULAIR; Flonase; Excedrin

Current Illness:

ID: 1482096
Sex: M
Age:
State: NJ

Vax Date: 03/24/2021
Onset Date: 03/24/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Muscle pain; tremor; This is a spontaneous report received from a contactable consumer, the patient. A 42-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EL3247) via an unspecified route of administration on the left arm on 24Mar2021 at 10:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was not allergic to medications, food or other products. Concomitant medications were not reported. The patient did not receive any other vaccine within four weeks of receiving the second dose COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: Unknown) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. The patient experienced muscle pain and tremor on 24Mar2021 at 22:00. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event muscle pain and tremor was resolving at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482097
Sex: M
Age:
State: IL

Vax Date:
Onset Date:
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Fatigue; This is a spontaneous report received from a contactable consumer. A male patient of unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration on an unspecified date, as a single dose, for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient experienced fatigue on an unspecified date. The patient did not receive any treatment for the reported event fatigue. The clinical outcome of event fatigue was resolving at the time of this report. No follow-up attempts are needed. Information about lot/ batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1482098
Sex: F
Age:
State: MA

Vax Date: 03/17/2021
Onset Date: 03/17/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 17Mar2021 at 12:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccine within 4 weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 17Mar2021 at 12:00, the patient was 9 days out and had a lot of shortness of breath, jaw pain, fatigue, night sweats and generally feeling not well. This was after a single dose and never had COVID. It was unknown if the patient received any treatment for the reported events. The adverse events resulted in emergency room/department or urgent care visit. The outcome of the events lot of shortness of breath, jaw pain, fatigue, night sweats and generally feeling not well were not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1482099
Sex: F
Age:
State: TX

Vax Date: 03/24/2021
Onset Date: 03/25/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: 9Concomitant medications were reported as yes. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: FN6205) via an unspecified route of administration in right arm on 03March2021 at 12:45 (at the age of 65-years-old), as a single dose for COVID-19 immunisation. The patient had reported no allergies to medications, food or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since having the vaccine. On 25Mar2021 at 07:30, the patient experienced nausea and joint pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcomes for the events nausea and joint pain were recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482100
Sex: F
Age:
State: MI

Vax Date: 03/23/2021
Onset Date: 03/23/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: This is a spontaneous report from a contactable consumer, patient. A 46-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3248), via an unspecified route of administration in the left arm on 23Mar2021 at 10:00 (age at vaccination was 46-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any known allergies. The concomitant medications included fesoterodine fumarate (TOVIAZ) and loratadine (CLARITIN) for an unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3248), via an unspecified route of administration in the left arm on 02Mar2021 at 10:00 (at the age of 46-years old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 23Mar2021 at 18:00, the patient experienced exhaustion. The patient did not receive any treatment for the reported event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of exhaustion was resolved on an unspecified date in Mar2021. No follow-up attempts are needed. No further information expected.

Other Meds: Claritin; TOVIAZ

Current Illness:

ID: 1482101
Sex: F
Age:
State: CA

Vax Date: 03/25/2021
Onset Date: 03/26/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Body pain; Sore arm; Fever 101.6; This is a spontaneous report from a contactable company representative, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955), via an unspecified route of administration in the right arm on 25Mar2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any concomitant medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 26Mar2021, the patient had sore arm, body pain and fever 101.6. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events sore arm, body pain and fever 101.6. The clinical outcomes of the events sore arm, body pain and fever 101.6 were not recovered at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1482102
Sex: F
Age:
State: CT

Vax Date: 03/25/2021
Onset Date: 03/25/2021
Rec V Date: 07/18/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: A 61-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via an unspecified route of administration in the left arm on 25Mar2021 at 13:30 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included atorvastatin 20 mg (MANUFACTURER UNKNOWN), amlodipine besilate (NORVASC) 5mg and magnesium 400 (MANUFACTURER UNKNOWN) (unit unspecified) for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EL3247) via an unspecified route of administration in the left arm on 04Mar2021 (at an age of 61-year-old) at 11:30, as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 25Mar2021 at 13:30 (immediately after vaccination), the patient experienced change in saliva flow. On 26Mar2021 at 06:30 (in the next morning), the patient experienced 103.1 F temperature, muscle ache and joint ache. The patient did not receive treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events changes in saliva flow, 103.1 F temperature, muscle ache and joint ache was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ATORVASTATIN; NORVASC; MAGNESIUM

Current Illness:

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm